Bioactive materials are part of the biomaterial family and are increasingly becoming popular due to their ability to react with body fluids and tissues without having a negative impact on the human health. They are extensively used as tissue replacement and tissue repair materials in surgical procedures. Bioactive materials are manufactured from materials such as ceramics, glass, glass-ceramics, and composites. The major end-users of bioactive materials are the Medical sector, followed by the Dentistry and Cosmetics sectors. Bioactive materials are commercially available in forms such as powders and nano-powders, granules, and injectable products and coatings.
Analysts forecast the Global Bioactive Material Market to grow at a CAGR of 13.30 percent over the period 2013-2018.
The report recognizes the following companies as the key players in the Global Bioactive Material Market: Biomet Inc., DePuy Synthes Inc., Medtronic Inc., Stryker Corp. and Zimmer Holdings Inc.
Other Prominent Vendors in the market are: 3Di, Aap Implantate, Arthrex, Baxter, Berkeley, Biomatlante, Curasan, Dentsply, Heraeus Kulzer, Integra Life Science, Kyocera, Novabone, Takiron and Wright Medical.
One of the major trends in the market is the unique properties of bioactive material, making it useful in different application sectors such as hard tissue repair, soft tissue repair, and tissue engineering.
Get discount on the Report @ http://www.sandlerresearch.org/discount?rname=23278 .
Covered in this Report
The report covers the present scenario and the growth prospects of the Global Bioactive Material market for the period 2014-2018. The Global Bioactive Material market can be segmented into three: Bioactive Glass, Bioactive Ceramics, and Composites.
Global Bioactive Material Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the APAC region, Europe, and North America; it also covers the Global Bioactive Material market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
According to the report, increase in aging population is one of the major drivers in the market. There will be an increased number of trauma, spinal and orthobiological surgeries because of the increased aging population, which will push the demand for bioactive materials.
Further, the report states that one of the main challenges that the market faces is the high cost of technology used to manufacture bioactive material. Bioactive material uses sol-gel technology for its preparation and uses in various biomedical applications, and the cost of this technology is very high.
